Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a Phase III randomized controlled multi‐center trial comparing anlotinib plus Gemcitabine/Cisplatin with placebo plus Gemcitabine/Cisplatin in previous untreated patients with recurrent/metastatic Nasopharyngeal Carcinoma, in order to verify the efficacy and security of anlotinib in mNPC patients.
Epistemonikos ID: 73e955cbf3c8d9371dd8061e57bea9bfe402560b
First added on: May 21, 2024